(VIANEWS) – The Innrs Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.
We, at Via News, will follow this AI algorithm and publish the results every week day.
Yesterday’s AI prediction for today would produce a ROI of -0.54% if an investor was to invest following yesterday’s Innrs AI suggestion.
See the data in the table below.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| Coca-Cola Consolidated (COKE) | 84.18% | $599.19 | 10.34% ✅ |
| Kodak (KODK) | 84.85% | $3 | 2.42% ✅ |
| Uber (UBER) | 83.99% | $36.97 | 1% ✅ |
| Biogen (BIIB) | 83.77% | $315.72 | 0.79% ✅ |
| Hormel Foods (HRL) | 88.32% | $41.92 | 0.74% ✅ |
| General Mills (GIS) | 88.3% | $90.97 | 0.72% ✅ |
| McCormick & Company (MKC) | 88.14% | $90.39 | 0.19% ✅ |
| Exelon (EXC) | 83.83% | $43.65 | -0.19% |
| Unilever (UL) | 88.23% | $56.87 | -0.34% |
| Smith & Nephew (SNN) | 84.03% | $32.57 | -0.34% |
| Mastercard (MA) | 84.01% | $383.9 | -0.43% |
| Coca-Cola (KO) | 92.9% | $65.64 | -0.44% |
| Intuitive Surgical (ISRG) | 87.42% | $312.52 | -0.57% |
| Yum! (YUM) | 89.27% | $140.34 | -0.74% |
| Electronic Arts (EA) | 87.38% | $127.42 | -0.82% |
| HCA Holdings (HCA) | 88.65% | $281.18 | -0.9% |
| Air Products and Chemicals (APD) | 83.93% | $303.39 | -1.07% |
| America Movil (AMX) | 84% | $21.86 | -1.16% |
| Johnson & Johnson (JNJ) | 87.15% | $169.28 | -1.37% |
| Amicus Therapeutics (FOLD) | 88.54% | $12.03 | -1.5% |
| Kimberly (KMB) | 84.29% | $148.91 | -1.57% |
| Kellogg Company (K) | 83.98% | $72.99 | -1.73% |
| Laboratory Corporation of America Holdings (LH) | 88.13% | $229.79 | -1.9% |
| Tenet Healthcare (THC) | 88.95% | $71.24 | -2.09% |
| ConAgra Foods (CAG) | 93.47% | $38.75 | -2.26% |
| Fifth Third Bancorp (FITBI) | 88.93% | $24.62 | -3.16% |
| Incyte Corporation (INCY) | 88.59% | $70.26 | -3.64% |
| Citizens Financial Group (CFG) | 92.91% | $26.62 | -5.04% |
1. Coca-Cola Consolidated (COKE)
Coca-Cola Consolidated has been having an accuracy rate of 84.18% over the last 10 sessions. Previous close price was $596.04 the AI prediction was $599.19 and today’s closing price was $657.69. The intraday ROI for Coca-Cola Consolidated (COKE) was 10.34%.
Shares of Coca-Cola Consolidated jumped by a staggering 23.73% in from $529.49 to $655.14 at 22:29 EST on Thursday, following the last session’s upward trend. NASDAQ is dropping 0.49% to $11,966.40, after four sequential sessions in a row of losses.
Coca-Cola Consolidated, Inc., together with its subsidiaries, manufactures, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States.
Earnings Per Share
As for profitability, Coca-Cola Consolidated has a trailing twelve months EPS of $45.74.
PE Ratio
Coca-Cola Consolidated has a trailing twelve months price to earnings ratio of 14.32. Meaning, the purchaser of the share is investing $14.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.08%.
Volatility
Coca-Cola Consolidated’s last week, last month’s, and last quarter’s current intraday variation average was 2.89%, 1.10%, and 1.54%.
Coca-Cola Consolidated’s highest amplitude of average volatility was 3.19% (last week), 1.46% (last month), and 1.54% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coca-Cola Consolidated’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca-Cola Consolidated’s EBITDA is 33.86.
Moving Average
Coca-Cola Consolidated’s value is way higher than its 50-day moving average of $537.67 and way above its 200-day moving average of $496.88.
More news about Coca-Cola Consolidated.
2. Kodak (KODK)
Kodak has been having an accuracy rate of 84.85% over the last 10 sessions. Previous close price was $3.3 the AI prediction was $3 and today’s closing price was $3.22. The intraday ROI for Kodak (KODK) was 2.42%.
Shares of Kodak fell by a staggering 22.98% in from $4.18 to $3.22 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is falling 0.76% to $15,117.67, after four successive sessions in a row of losses.
Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide.
Earnings Per Share
As for profitability, Kodak has a trailing twelve months EPS of $0.16.
PE Ratio
Kodak has a trailing twelve months price to earnings ratio of 20.12. Meaning, the purchaser of the share is investing $20.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.34%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kodak’s EBITDA is 20.97.
Moving Average
Kodak’s value is way below its 50-day moving average of $3.66 and way under its 200-day moving average of $4.40.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 1.2B for the twelve trailing months.
More news about Kodak.
3. Uber (UBER)
Uber has been having an accuracy rate of 83.99% over the last 10 sessions. Previous close price was $37.87 the AI prediction was $36.97 and today’s closing price was $37.49. The intraday ROI for Uber (UBER) was 1%.
Shares of Uber rose by a staggering 21.48% in from $31.05 to $37.72 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.76% to $15,117.67, after four successive sessions in a row of losses.
Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and Asia excluding China and Southeast Asia.
Earnings Per Share
As for profitability, Uber has a trailing twelve months EPS of $-5.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.62%.
Previous days news about Uber
- According to Zacks on Wednesday, 3 May, "Uber Technologies, Inc. price-consensus-eps-surprise-chart | Uber Technologies, Inc. Quote", "For the second quarter of 2023, Uber expects gross bookings of $33 billion-$34 billion. "
More news about Uber.
4. Biogen (BIIB)
Biogen has been having an accuracy rate of 83.77% over the last 10 sessions. Previous close price was $311.1 the AI prediction was $315.72 and today’s closing price was $313.57. The intraday ROI for Biogen (BIIB) was 0.79%.
Shares of Biogen rose by a staggering 10.24% in from $284.47 to $313.60 at 22:29 EST on Thursday, after two successive sessions in a row of gains. NASDAQ is sliding 0.49% to $11,966.40, after four consecutive sessions in a row of losses.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Earnings Per Share
As for profitability, Biogen has a trailing twelve months EPS of $21.96.
PE Ratio
Biogen has a trailing twelve months price to earnings ratio of 14.28. Meaning, the purchaser of the share is investing $14.28 for every dollar of annual earnings.
Volume
Today’s last reported volume for Biogen is 981137 which is 4.13% above its average volume of 942136.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 28% and a negative 13.8%, respectively.
Moving Average
Biogen’s value is way higher than its 50-day moving average of $275.75 and way above its 200-day moving average of $261.49.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Biogen’s stock is considered to be oversold (<=20).
More news about Biogen.
5. Hormel Foods (HRL)
Hormel Foods has been having an accuracy rate of 88.32% over the last 10 sessions. Previous close price was $40.61 the AI prediction was $41.92 and today’s closing price was $40.91. The intraday ROI for Hormel Foods (HRL) was 0.74%.
Shares of Hormel Foods jumped 0.96% in from $40.5 to $40.89 at 22:29 EST on Thursday, after four sequential sessions in a row of gains. NYSE is sliding 0.76% to $15,117.67, after four sequential sessions in a row of losses.
Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally.
Earnings Per Share
As for profitability, Hormel Foods has a trailing twelve months EPS of $1.78.
PE Ratio
Hormel Foods has a trailing twelve months price to earnings ratio of 22.97. Meaning, the purchaser of the share is investing $22.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
More news about Hormel Foods.
6. General Mills (GIS)
General Mills has been having an accuracy rate of 88.3% over the last 10 sessions. Previous close price was $88.76 the AI prediction was $90.97 and today’s closing price was $89.4. The intraday ROI for General Mills (GIS) was 0.72%.
Shares of General Mills jumped 2.63% in from $87 to $89.29 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is sliding 0.76% to $15,117.67, after four sequential sessions in a row of losses.
General Mills, Inc. manufactures and markets branded consumer foods worldwide.
Earnings Per Share
As for profitability, General Mills has a trailing twelve months EPS of $4.63.
PE Ratio
General Mills has a trailing twelve months price to earnings ratio of 19.29. Meaning, the purchaser of the share is investing $19.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.39%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
General Mills’s EBITDA is 3.1.
Volume
Today’s last reported volume for General Mills is 1374310 which is 56.37% below its average volume of 3150420.
Volatility
General Mills’s last week, last month’s, and last quarter’s current intraday variation average was 0.07%, 0.11%, and 0.78%.
General Mills’s highest amplitude of average volatility was 0.48% (last week), 0.47% (last month), and 0.78% (last quarter).
More news about General Mills.
7. McCormick & Company (MKC)
McCormick & Company has been having an accuracy rate of 88.14% over the last 10 sessions. Previous close price was $88.1 the AI prediction was $90.39 and today’s closing price was $88.27. The intraday ROI for McCormick & Company (MKC) was 0.19%.
Shares of McCormick & Company rose 3.54% in from $85.28 to $88.30 at 22:29 EST on Thursday, after three successive sessions in a row of gains. NYSE is falling 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry.
Earnings Per Share
As for profitability, McCormick & Company has a trailing twelve months EPS of $2.47.
PE Ratio
McCormick & Company has a trailing twelve months price to earnings ratio of 35.75. Meaning, the purchaser of the share is investing $35.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 6.39B for the twelve trailing months.
More news about McCormick & Company.
8. Exelon (EXC)
Exelon has been having an accuracy rate of 83.83% over the last 10 sessions. Previous close price was $42.64 the AI prediction was $43.65 and today’s closing price was $42.56. The intraday ROI for Exelon (EXC) was -0.19%.
Shares of Exelon fell 0.56% in from $42.92 to $42.68 at 22:29 EST on Thursday, following the last session’s upward trend. NASDAQ is sliding 0.49% to $11,966.40, after four successive sessions in a row of losses.
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada.
Earnings Per Share
As for profitability, Exelon has a trailing twelve months EPS of $2.08.
PE Ratio
Exelon has a trailing twelve months price to earnings ratio of 20.52. Meaning, the purchaser of the share is investing $20.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.
Volume
Today’s last reported volume for Exelon is 3968040 which is 47.35% below its average volume of 7537820.
Sales Growth
Exelon’s sales growth is negative 0.9% for the current quarter and 2.9% for the next.
More news about Exelon.
9. Unilever (UL)
Unilever has been having an accuracy rate of 88.23% over the last 10 sessions. Previous close price was $55.6 the AI prediction was $56.87 and today’s closing price was $55.41. The intraday ROI for Unilever (UL) was -0.34%.
Shares of Unilever jumped 3.96% in from $53.29 to $55.40 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is sliding 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Unilever PLC operates as a fast-moving consumer goods company.
Earnings Per Share
As for profitability, Unilever has a trailing twelve months EPS of $3.28.
PE Ratio
Unilever has a trailing twelve months price to earnings ratio of 16.89. Meaning, the purchaser of the share is investing $16.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.9%.
More news about Unilever.
10. Smith & Nephew (SNN)
Smith & Nephew has been having an accuracy rate of 84.03% over the last 10 sessions. Previous close price was $32.12 the AI prediction was $32.57 and today’s closing price was $32.01. The intraday ROI for Smith & Nephew (SNN) was -0.34%.
Shares of Smith & Nephew jumped by a staggering 12.98% in from $28.36 to $32.04 at 22:29 EST on Thursday, after five sequential sessions in a row of losses. NYSE is falling 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.51.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 62.82. Meaning, the purchaser of the share is investing $62.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.12%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Smith & Nephew’s stock is considered to be overbought (>=80).
Volatility
Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.59%, a positive 0.66%, and a positive 1.07%.
Smith & Nephew’s highest amplitude of average volatility was 0.59% (last week), 1.11% (last month), and 1.07% (last quarter).
Moving Average
Smith & Nephew’s worth is way higher than its 50-day moving average of $28.58 and way higher than its 200-day moving average of $26.50.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.5%.
More news about Smith & Nephew.
11. Mastercard (MA)
Mastercard has been having an accuracy rate of 84.01% over the last 10 sessions. Previous close price was $377.76 the AI prediction was $383.9 and today’s closing price was $376.12. The intraday ROI for Mastercard (MA) was -0.43%.
Shares of Mastercard rose 3.18% in from $363.83 to $375.40 at 22:29 EST on Thursday, following the last session’s upward trend. NYSE is sliding 0.76% to $15,117.67, after four successive sessions in a row of losses.
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally.
Earnings Per Share
As for profitability, Mastercard has a trailing twelve months EPS of $10.01.
PE Ratio
Mastercard has a trailing twelve months price to earnings ratio of 37.5. Meaning, the purchaser of the share is investing $37.5 for every dollar of annual earnings.
Yearly Top and Bottom Value
Mastercard’s stock is valued at $375.40 at 22:29 EST, below its 52-week high of $390.00 and way higher than its 52-week low of $276.87.
Moving Average
Mastercard’s worth is higher than its 50-day moving average of $360.56 and higher than its 200-day moving average of $344.56.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Mastercard’s stock is considered to be overbought (>=80).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 4, 2023, the estimated forward annual dividend rate is 2.28 and the estimated forward annual dividend yield is 0.6%.
More news about Mastercard.
12. Coca-Cola (KO)
Coca-Cola has been having an accuracy rate of 92.9% over the last 10 sessions. Previous close price was $64 the AI prediction was $65.64 and today’s closing price was $63.72. The intraday ROI for Coca-Cola (KO) was -0.44%.
Shares of Coca-Cola rose 1.29% in from $62.81 to $63.62 at 22:29 EST on Thursday, following the last session’s upward trend. NYSE is dropping 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide.
Earnings Per Share
As for profitability, Coca-Cola has a trailing twelve months EPS of $2.26.
PE Ratio
Coca-Cola has a trailing twelve months price to earnings ratio of 28.15. Meaning, the purchaser of the share is investing $28.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.83%.
More news about Coca-Cola.
13. Intuitive Surgical (ISRG)
Intuitive Surgical has been having an accuracy rate of 87.42% over the last 10 sessions. Previous close price was $304.96 the AI prediction was $312.52 and today’s closing price was $303.21. The intraday ROI for Intuitive Surgical (ISRG) was -0.57%.
Shares of Intuitive Surgical jumped by a staggering 17.49% in from $258.05 to $303.18 at 22:29 EST on Thursday, following the last session’s downward trend. NASDAQ is falling 0.49% to $11,966.40, after four successive sessions in a row of losses.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $3.66.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 82.84. Meaning, the purchaser of the share is investing $82.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.39%.
Sales Growth
Intuitive Surgical’s sales growth is 14.1% for the present quarter and 17.2% for the next.
Volume
Today’s last reported volume for Intuitive Surgical is 1048720 which is 36.76% below its average volume of 1658560.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 15.8% and 17.6%, respectively.
More news about Intuitive Surgical.
14. Yum! (YUM)
Yum! has been having an accuracy rate of 89.27% over the last 10 sessions. Previous close price was $137.33 the AI prediction was $140.34 and today’s closing price was $136.32. The intraday ROI for Yum! (YUM) was -0.74%.
Shares of Yum! rose 3.23% in from $132.04 to $136.30 at 22:29 EST on Thursday, after five sequential sessions in a row of losses. NYSE is sliding 0.76% to $15,117.67, after four successive sessions in a row of losses.
Yum!
Earnings Per Share
As for profitability, Yum! has a trailing twelve months EPS of $4.57.
PE Ratio
Yum! has a trailing twelve months price to earnings ratio of 29.82. Meaning, the purchaser of the share is investing $29.82 for every dollar of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Yum!’s stock is considered to be overbought (>=80).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 20, 2023, the estimated forward annual dividend rate is 2.42 and the estimated forward annual dividend yield is 1.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 6.84B for the twelve trailing months.
More news about Yum!.
15. Electronic Arts (EA)
Electronic Arts has been having an accuracy rate of 87.38% over the last 10 sessions. Previous close price was $125.04 the AI prediction was $127.42 and today’s closing price was $124.01. The intraday ROI for Electronic Arts (EA) was -0.82%.
Shares of Electronic Arts fell 1.65% in from $126.14 to $124.06 at 22:29 EST on Thursday, after three successive sessions in a row of losses. NASDAQ is dropping 0.49% to $11,966.40, after four consecutive sessions in a row of losses.
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide.
Earnings Per Share
As for profitability, Electronic Arts has a trailing twelve months EPS of $3.71.
PE Ratio
Electronic Arts has a trailing twelve months price to earnings ratio of 33.44. Meaning, the purchaser of the share is investing $33.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.
More news about Electronic Arts.
16. HCA Holdings (HCA)
HCA Holdings has been having an accuracy rate of 88.65% over the last 10 sessions. Previous close price was $280.15 the AI prediction was $281.18 and today’s closing price was $277.63. The intraday ROI for HCA Holdings (HCA) was -0.9%.
Shares of HCA Holdings rose 2.31% in from $270.64 to $276.89 at 22:29 EST on Thursday, after five successive sessions in a row of losses. NYSE is sliding 0.76% to $15,117.67, after four successive sessions in a row of losses.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $19.7.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 14.06. Meaning, the purchaser of the share is investing $14.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2139.94%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 0.7% and 3.8%, respectively.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 14, 2023, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 0.84%.
More news about HCA Holdings.
17. Air Products and Chemicals (APD)
Air Products and Chemicals has been having an accuracy rate of 83.93% over the last 10 sessions. Previous close price was $294.22 the AI prediction was $303.39 and today’s closing price was $291.07. The intraday ROI for Air Products and Chemicals (APD) was -1.07%.
Shares of Air Products and Chemicals jumped 2.53% in from $283.41 to $290.58 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.76% to $15,117.67, after four sequential sessions in a row of losses.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally.
Earnings Per Share
As for profitability, Air Products and Chemicals has a trailing twelve months EPS of $10.14.
PE Ratio
Air Products and Chemicals has a trailing twelve months price to earnings ratio of 28.66. Meaning, the purchaser of the share is investing $28.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.84%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Air Products and Chemicals’s EBITDA is 67.83.
Volatility
Air Products and Chemicals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.10%, a positive 0.16%, and a positive 0.99%.
Air Products and Chemicals’s highest amplitude of average volatility was 0.77% (last week), 0.84% (last month), and 0.99% (last quarter).
Volume
Today’s last reported volume for Air Products and Chemicals is 421838 which is 57.27% below its average volume of 987257.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 2.38%.
More news about Air Products and Chemicals.
18. America Movil (AMX)
America Movil has been having an accuracy rate of 84% over the last 10 sessions. Previous close price was $21.6 the AI prediction was $21.86 and today’s closing price was $21.35. The intraday ROI for America Movil (AMX) was -1.16%.
Shares of America Movil rose 1.38% in from $21.04 to $21.33 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally.
Earnings Per Share
As for profitability, America Movil has a trailing twelve months EPS of $1.43.
PE Ratio
America Movil has a trailing twelve months price to earnings ratio of 14.92. Meaning, the purchaser of the share is investing $14.92 for every dollar of annual earnings.
More news about America Movil.
19. Johnson & Johnson (JNJ)
Johnson & Johnson has been having an accuracy rate of 87.15% over the last 10 sessions. Previous close price was $164.39 the AI prediction was $169.28 and today’s closing price was $162.13. The intraday ROI for Johnson & Johnson (JNJ) was -1.37%.
Shares of Johnson & Johnson slid 1.84% in from $165.31 to $162.27 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is falling 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide.
Earnings Per Share
As for profitability, Johnson & Johnson has a trailing twelve months EPS of $4.77.
PE Ratio
Johnson & Johnson has a trailing twelve months price to earnings ratio of 34.02. Meaning, the purchaser of the share is investing $34.02 for every dollar of annual earnings.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 21, 2023, the estimated forward annual dividend rate is 4.76 and the estimated forward annual dividend yield is 2.88%.
Volume
Today’s last reported volume for Johnson & Johnson is 2726440 which is 65.92% below its average volume of 8001720.
Yearly Top and Bottom Value
Johnson & Johnson’s stock is valued at $162.27 at 22:29 EST, way under its 52-week high of $183.35 and higher than its 52-week low of $150.11.
More news about Johnson & Johnson.
20. Amicus Therapeutics (FOLD)
Amicus Therapeutics has been having an accuracy rate of 88.54% over the last 10 sessions. Previous close price was $12.03 the AI prediction was $12.03 and today’s closing price was $11.85. The intraday ROI for Amicus Therapeutics (FOLD) was -1.5%.
Shares of Amicus Therapeutics rose 7.04% in from $11.08 to $11.86 at 22:29 EST on Thursday, following the last session’s downward trend. NASDAQ is dropping 0.49% to $11,966.40, after four consecutive sessions in a row of losses.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases.
Earnings Per Share
As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -109.93%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amicus Therapeutics’s EBITDA is -61.15.
Sales Growth
Amicus Therapeutics’s sales growth is 6.2% for the present quarter and 11.9% for the next.
Volume
Today’s last reported volume for Amicus Therapeutics is 1268110 which is 40.01% below its average volume of 2113950.
More news about Amicus Therapeutics.
21. Kimberly (KMB)
Kimberly has been having an accuracy rate of 84.29% over the last 10 sessions. Previous close price was $146.71 the AI prediction was $148.91 and today’s closing price was $144.41. The intraday ROI for Kimberly (KMB) was -1.57%.
Shares of Kimberly jumped 6.99% in from $135.46 to $144.93 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is dropping 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide.
Earnings Per Share
As for profitability, Kimberly has a trailing twelve months EPS of $5.82.
PE Ratio
Kimberly has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing $24.9 for every dollar of annual earnings.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kimberly’s EBITDA is 2.8.
More news about Kimberly.
22. Kellogg Company (K)
Kellogg Company has been having an accuracy rate of 83.98% over the last 10 sessions. Previous close price was $71.62 the AI prediction was $72.99 and today’s closing price was $70.38. The intraday ROI for Kellogg Company (K) was -1.73%.
Shares of Kellogg Company jumped 3.47% in from $68 to $70.36 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is dropping 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Kellogg Company, together with its subsidiaries, manufactures and markets snacks and convenience foods.
Earnings Per Share
As for profitability, Kellogg Company has a trailing twelve months EPS of $2.79.
PE Ratio
Kellogg Company has a trailing twelve months price to earnings ratio of 25.22. Meaning, the purchaser of the share is investing $25.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kellogg Company’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Kellogg Company’s stock is valued at $70.36 at 22:29 EST, under its 52-week high of $77.17 and way above its 52-week low of $63.74.
Volume
Today’s last reported volume for Kellogg Company is 2751170 which is 29.32% above its average volume of 2127280.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 2.36 and the estimated forward annual dividend yield is 3.52%.
More news about Kellogg Company.
23. Laboratory Corporation of America Holdings (LH)
Laboratory Corporation of America Holdings has been having an accuracy rate of 88.13% over the last 10 sessions. Previous close price was $226.03 the AI prediction was $229.79 and today’s closing price was $221.74. The intraday ROI for Laboratory Corporation of America Holdings (LH) was -1.9%.
Shares of Laboratory Corporation of America Holdings fell 5.37% in from $234.7 to $222.10 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is falling 0.76% to $15,117.67, after four sequential sessions in a row of losses.
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Earnings Per Share
As for profitability, Laboratory Corporation of America Holdings has a trailing twelve months EPS of $11.14.
PE Ratio
Laboratory Corporation of America Holdings has a trailing twelve months price to earnings ratio of 19.94. Meaning, the purchaser of the share is investing $19.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.55%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.4%, now sitting on 14.88B for the twelve trailing months.
Moving Average
Laboratory Corporation of America Holdings’s worth is below its 50-day moving average of $233.70 and below its 200-day moving average of $234.96.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Laboratory Corporation of America Holdings’s EBITDA is 106.9.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 16, 2023, the estimated forward annual dividend rate is 2.88 and the estimated forward annual dividend yield is 1.26%.
More news about Laboratory Corporation of America Holdings.
24. Tenet Healthcare (THC)
Tenet Healthcare has been having an accuracy rate of 88.95% over the last 10 sessions. Previous close price was $69.92 the AI prediction was $71.24 and today’s closing price was $68.46. The intraday ROI for Tenet Healthcare (THC) was -2.09%.
Shares of Tenet Healthcare jumped by a staggering 12.33% in from $60.75 to $68.24 at 22:29 EST on Thursday, after five consecutive sessions in a row of losses. NYSE is dropping 0.76% to $15,117.67, after four successive sessions in a row of losses.
Tenet Healthcare Corporation operates as a diversified healthcare services company.
Earnings Per Share
As for profitability, Tenet Healthcare has a trailing twelve months EPS of $3.76.
PE Ratio
Tenet Healthcare has a trailing twelve months price to earnings ratio of 18.15. Meaning, the purchaser of the share is investing $18.15 for every dollar of annual earnings.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tenet Healthcare’s EBITDA is 1.11.
More news about Tenet Healthcare.
25. ConAgra Foods (CAG)
ConAgra Foods has been having an accuracy rate of 93.47% over the last 10 sessions. Previous close price was $38.49 the AI prediction was $38.75 and today’s closing price was $37.62. The intraday ROI for ConAgra Foods (CAG) was -2.26%.
Shares of ConAgra Foods slid 1.35% in from $38.23 to $37.71 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is sliding 0.76% to $15,117.67, after four consecutive sessions in a row of losses.
Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America.
Earnings Per Share
As for profitability, ConAgra Foods has a trailing twelve months EPS of $1.67.
PE Ratio
ConAgra Foods has a trailing twelve months price to earnings ratio of 22.58. Meaning, the purchaser of the share is investing $22.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.05%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 12.21B for the twelve trailing months.
More news about ConAgra Foods.
26. Fifth Third Bancorp (FITBI)
Fifth Third Bancorp has been having an accuracy rate of 88.93% over the last 10 sessions. Previous close price was $24.38 the AI prediction was $24.62 and today’s closing price was $23.61. The intraday ROI for Fifth Third Bancorp (FITBI) was -3.16%.
Shares of Fifth Third Bancorp jumped 1.33% in from $23.24 to $23.55 at 22:29 EST on Thursday, after three consecutive sessions in a row of losses. NASDAQ is dropping 0.49% to $11,966.40, after four sequential sessions in a row of losses.
Fifth Third Bancorp operates as a diversified financial services company in the United States.
Earnings Per Share
As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $3.48.
PE Ratio
Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 6.76. Meaning, the purchaser of the share is investing $6.76 for every dollar of annual earnings.
More news about Fifth Third Bancorp.
27. Incyte Corporation (INCY)
Incyte Corporation has been having an accuracy rate of 88.59% over the last 10 sessions. Previous close price was $68.69 the AI prediction was $70.26 and today’s closing price was $66.19. The intraday ROI for Incyte Corporation (INCY) was -3.64%.
Shares of Incyte Corporation fell by a staggering 11.11% in from $74.73 to $66.43 at 22:29 EST on Thursday, after three consecutive sessions in a row of losses. NASDAQ is falling 0.49% to $11,966.40, after four successive sessions in a row of losses.
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.
Earnings Per Share
As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.48.
PE Ratio
Incyte Corporation has a trailing twelve months price to earnings ratio of 44.89. Meaning, the purchaser of the share is investing $44.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.37%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Incyte Corporation’s EBITDA is 183.73.
Yearly Top and Bottom Value
Incyte Corporation’s stock is valued at $66.43 at 22:29 EST, way below its 52-week high of $86.29 and above its 52-week low of $65.07.
Volatility
Incyte Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.01%, a negative 0.56%, and a positive 1.29%.
Incyte Corporation’s highest amplitude of average volatility was 3.64% (last week), 1.52% (last month), and 1.29% (last quarter).
More news about Incyte Corporation.
28. Citizens Financial Group (CFG)
Citizens Financial Group has been having an accuracy rate of 92.91% over the last 10 sessions. Previous close price was $26.17 the AI prediction was $26.62 and today’s closing price was $24.85. The intraday ROI for Citizens Financial Group (CFG) was -5.04%.
Shares of Citizens Financial Group fell by a staggering 15.09% in from $29.27 to $24.85 at 22:29 EST on Thursday, after four sequential sessions in a row of losses. NYSE is falling 0.76% to $15,117.67, after four sequential sessions in a row of losses.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, National Association that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, corporations, and institutions in the United States.
Earnings Per Share
As for profitability, Citizens Financial Group has a trailing twelve months EPS of $4.17.
PE Ratio
Citizens Financial Group has a trailing twelve months price to earnings ratio of 5.96. Meaning, the purchaser of the share is investing $5.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.8%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Citizens Financial Group’s stock is considered to be overbought (>=80).
Sales Growth
Citizens Financial Group’s sales growth is 30.1% for the ongoing quarter and 8.6% for the next.
More news about Citizens Financial Group.
